The Association between Serum Neutrophil Gelatinase-Associated Lipocalin and Depression in Patients with Type 2 Diabetes Mellitus
- 10 February 2022
- journal article
- research article
- Published by Taylor & Francis in Experimental Aging Research
- Vol. 48 (5) , 444-454
Abstract
Patients wtih type 2 diabetes mellitus (DM) have an increased risk of depressive symptoms. Whether serum neutrophil gelatinase-associated lipocalin (NGAL) is associated with depressive symptoms in ...Keywords
This publication has 31 references indexed in Scilit:
- Association of depressive disorders, depression characteristics and antidepressant medication with inflammationTranslational Psychiatry, 2012
- The Netherlands study of depression in older persons (NESDO); a prospective cohort studyBMC Research Notes, 2011
- Lipocalin-2 controls neuronal excitability and anxiety by regulating dendritic spine formation and maturationProceedings of the National Academy of Sciences, 2011
- Lipocalin 2 in the central nervous system host response to systemic lipopolysaccharide administrationJournal of Neuroinflammation, 2011
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-AnalysisNeuropsychopharmacology, 2011
- Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis of Type 1 Cardio-Renal Syndrome in the General WardClinical Journal of the American Society of Nephrology, 2011
- Limited effect of screening for depression with written feedback in outpatients with diabetes mellitus: a randomised controlled trialDiabetologia, 2011
- Bidirectional Association Between Depression and Type 2 Diabetes Mellitus in WomenArchives of internal medicine (1960), 2010
- Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and functionHippocampus, 2010
- The CES-D ScaleApplied Psychological Measurement, 1977